Xiaolin Zhang

Xiaolin Zhang has a wide range of work experience in the pharmaceutical industry. Xiaolin is the Founder, Chairman, and CEO of Dizal Pharmaceutical, a company they established in 2017. Prior to that, they worked at AstraZeneca for nearly 20 years, starting in 1998. During their time at AstraZeneca, they served as the Global Vice President of Innovative Medicine and Early Development Asia. Before joining AstraZeneca, Xiaolin Zhang had a research fellowship at Boston University College of Engineering from 1996 to 1998.

Xiaolin Zhang began their education in 1989 at Oregon State University, where they pursued a Doctor of Philosophy degree in Molecular Genetics. This phase lasted from 1989 to 1995. Following that, from 1994 to 1996, Xiaolin Zhang attended Harvard Medical School for a Postdoc degree in Oncology and Cancer Biology.